Legal status · United Kingdom
Is FOXO4-DRI legal in the United Kingdom?
No. FOXO4-DRI is not an approved medicine in the United Kingdom; its classification is "Not licensed". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Preliminary.
FOXO4-DRI in the United Kingdom at a glance
| Classification | Not licensed |
|---|---|
| MHRA approval status | Not approved by MHRA |
| Evidence level | Preliminary (research strength: Preliminary) |
| Reviewed | Sep 2026 |
Classification and note come from the FOXO4-DRI profile, checked against Medicines and Healthcare products Regulatory Agency (MHRA) listings at the reviewed date.
What this means
- 01
No product containing FOXO4-DRI is approved by MHRA for any use in the United Kingdom, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United Kingdom. This page is general information, not legal advice.
What FOXO4-DRI is
An experimental senolytic peptide that selectively triggers death of senescent cells in animal studies.
FOXO4-DRI is a designed peptide that disrupts the interaction between FOXO4 and p53 inside senescent cells, releasing p53 to trigger their apoptosis. In progeroid and aged mice it reversed markers of frailty and improved organ function.
Mechanism: Disrupts the FOXO4-p53 interaction selectively in senescent cells, allowing p53 to initiate targeted apoptosis of those cells.
Regulatory history: Not FDA-approved; experimental
How MHRA treats this kind of product
Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.
The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for FOXO4-DRI at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
FOXO4-DRI in other countries
Frequently asked questions
Is FOXO4-DRI legal in the United Kingdom?
No. FOXO4-DRI is not an approved medicine in the United Kingdom; its classification is "Not licensed". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Preliminary.
Can I buy FOXO4-DRI in the United Kingdom?
No approved product exists to buy. In the United Kingdom FOXO4-DRI is classified as "Not licensed", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is FOXO4-DRI MHRA approved?
No. In the United Kingdom FOXO4-DRI is classified as "Not licensed", which is not a MHRA marketing approval. For comparison, the US FDA status is: Not FDA-approved; experimental. Evidence level: Preliminary.
Related compounds in the United Kingdom
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for FOXO4-DRI live on its compound profile.
FOXO4-DRI profileThis page is general information about the regulatory status of FOXO4-DRI in the United Kingdom, current as of Sep 2026. It is not legal advice, and classifications change; check Medicines and Healthcare products Regulatory Agency directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.